BioBlastLogo.jpg
BioBlast Pharma Enhances Leadership Team
January 11, 2016 08:00 ET | Bioblast Pharma Ltd.
NEW HAVEN, Conn., Jan. 11, 2016 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage biotechnology company committed to developing meaningful therapies for patients with rare...
STRATA Skin Sciences Logo.jpg
STRATA Skin Sciences, Inc. Announces Refinancing of $10.0 Million of Short-Term Debt
January 05, 2016 08:00 ET | STRATA Skin Sciences, Inc.
HORSHAM, Pa., Jan. 05, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:SSKN)  On December 30, 2015, STRATA Skin Sciences, Inc. (“STRATA Skin”) entered into a $12.0 million Credit and Security Agreement (the...
STRATA Skin Sciences Logo.jpg
MELA Sciences Announces That Its Corporate Name Change to STRATA Skin Sciences Will Be Effective January 5, 2016
January 04, 2016 13:00 ET | STRATA Skin Sciences, Inc.
HORSHAM, Pa., Jan. 04, 2016 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), today announced that its corporate name change to STRATA Skin Sciences, Inc. will be effective Tuesday, January...
STRATA Skin Sciences Logo.jpg
MELA Sciences Announces Corporate Name Change to STRATA Skin Sciences to Reflect Broader Dermatology Commitment
December 22, 2015 08:00 ET | STRATA Skin Sciences, Inc.
HORSHAM, Pa., Dec. 22, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), today announced that it will be changing its corporate name to STRATA Skin Sciences, Inc. effective Tuesday,...
MELA Sciences Reports Supplemental Financial Information on XTRAC(R) Recurring Revenue
November 13, 2015 14:21 ET | MELA Sciences
HORSHAM, Pa., Nov. 13, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA) reported today additional information related to its Third Quarter 2015 financial results press release dated November...
MELA Sciences Reports Third Quarter 2015 Financial Results
November 12, 2015 16:01 ET | MELA Sciences
HORSHAM, Pa., Nov. 12, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the treatment and...
MELA Sciences Appoints Christina L. Allgeier Chief Financial Officer
November 11, 2015 14:52 ET | MELA Sciences
HORSHAM, Pa., Nov. 11, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the treatment and...
MELA Sciences to Report Third Quarter Financial Results on Thursday, November 12
October 29, 2015 08:00 ET | MELA Sciences
HORSHAM, Pa., Oct. 29, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and...
MELA Sciences Announces Election of R. Rox Anderson, M.D., to Board of Directors
October 13, 2015 08:30 ET | MELA Sciences
HORSHAM, Pa., Oct. 13, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and...
MELA Sciences Reports Second Quarter 2015 Financial Results
August 13, 2015 16:01 ET | MELA Sciences
HORSHAM, Pa., Aug. 13, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and...